ELEVAI BIOSCIENCES
Dead / Abandoned — Abandoned — failure to respond (as of 29 Mar 2025)
What this means for you
This application is over — abandoned 21 Feb 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98533158
- Mark type
- Stylized text
- Filed
- 03 May 2024
- Abandoned
- 21 Feb 2025
- Attorney of record
- Rebecca S. Lessard
Goods and services
- Class 005 — Pharmaceuticals: Dietary and nutritional supplements; Probiotic supplements; Dietary and nutritional supplements, namely, probiotics with myostatin antigens; Dietary supplements for obesity management
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical and biotechnology fields; Biochemical research and development; Research and development of medicines, supplements, and probiotics; Consulting services in the fields of biotechnology, pharmaceutical research, and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Medical and scientific research in the field of treatment of chronic diseases; Pharmaceutical research and development; Research and development in the field of gene expression; Scientific research for medical purposes in the field of chronic diseases; Stem cell research services; Testing, inspection, research, or development of pharmaceutical preparations and medicines for gene therapy; Research and development in the field of antibodies; Research, development, engineering and testing services in the fields of immunopharmaceuticals
Owner
- ELEVAI LABS INC., Newport Beach, CA, US
Prosecution history
- 29 Mar 2025 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 29 Mar 2025 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 29 Mar 2025 — ASSIGNED TO EXAMINER
- 20 Nov 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 20 Nov 2024 — NON-FINAL ACTION E-MAILED
- 20 Nov 2024 — NON-FINAL ACTION WRITTEN
- 19 Nov 2024 — ASSIGNED TO EXAMINER
- 30 Oct 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 03 May 2024 — NEW APPLICATION ENTERED